BioSpace News Archive

Drug Development

Arecor announces Phase 1 of AT247 at ADA

AT247 delivers significantly accelerated absorption of insulin compared to best in class treatments NovoRapid® and Fiasp®

June 15, 2020
·
4 min read
Business

IRRAS Announces Promotion of Will Martin to President and Chief Commercial Officer

Added responsibilities underscore company’s focus on commercial growth for the IRRAflow® and Hummingbird product lines

June 15, 2020
·
2 min read
Business

Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer

Aridis Pharmaceuticals, Inc. announced that it has appointed Dr. Hasan Jafri as Chief Medical Officer. Dr. Jafri replaces Dr. Paul Mendelman who has been serving as the Company’s interim CMO since October, 2019 and will transition to the role of senior medical advisor to the Company.

June 15, 2020
·
7 min read
MolecuLight i:X® Platform Available to 9,000 Healthcare Facilities Through MAGNET GROUP GPO

Leading GPO Accepts MolecuLight i:X Point-of-Care Device for Detection of Bacteria and Digital Wound Measurement for its National Membership

June 15, 2020
·
4 min read
Genetown

Magenta Therapeutics and Beam Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate (ADC) MGTA-117 as Conditioning Regimen for Base Editing Therapies

MGTA-117 conditioning for precise depletion of cells in the bone marrow could potentially increase patients’ benefit from Beam’s base editing therapies for sickle cell disease and beta thalassemia

June 15, 2020
·
10 min read
Drug Development

IVERIC bio Announces Positive Zimura 18 Month Data Supporting the 12 Month Efficacy Findings

Continuous Positive Treatment Effect with Favorable Safety Profile in Geographic Atrophy Secondary to Age-Related Macular Degeneration in a Phase 3 Trial

June 15, 2020
·
11 min read
BioMidwest

Myriad Announces New Favorable Coverage Policies for Prolaris® from Three New Commercial Health Plans Including Major National Provider

Myriad Genetics, Inc., a leader in molecular diagnostics and precision medicine, announced that the company has received favorable coverage decisions for Prolaris® from three new commercial health plans including one of the top five national providers of health insurance.

June 15, 2020
·
6 min read
Drug Development

AGTC Launches Nationwide Mobile Vision Testing Program for Patients Enrolled in Its Ongoing Phase 1/2 Clinical Trials

Mobile vision testing unit enables X-linked retinitis pigmentosa and achromatopsia clinical trial patients to maintain important scheduled study assessments during COVID-19 pandemic

June 15, 2020
·
5 min read
Drug Development

BeyondSpring Announces Positive Topline Interim Results from PROTECTIVE-2 (Study 106) Phase 3 Trial Evaluating Superiority of Plinabulin in Combination with Neulasta for Chemotherapy-Induced Neutropenia Prevention

BeyondSpring, a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, announced positive topline results at the pre-specified interim analysis of its PROTECTIVE-2 Phase 3 trial, evaluating Plinabulin in combination with Neulasta versus Neulasta alone.

June 15, 2020
·
8 min read
Business

Medison Pharma and Alpha Tau Medical Announce a Collaboration in the Oncology Field in Central and Eastern Europe

Medison Pharma Trading AG, a fully owned subsidiary of Medison Pharma Ltd., and Alpha Tau Medical Ltd., the developer of a breakthrough alpha-radiation cancer therapy “Alpha DaRT,” are pleased to announce an exploratory collaboration in the oncology field in Central and Eastern Europe.

June 15, 2020
·
1 min read